Newsroom
Sorted by: Latest
-
DSGR Investors Have Opportunity to Join Distribution Solutions Group, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--DSGR Investors Have Opportunity to Join Distribution Solutions Group, Inc. Fraud Investigation with the Schall Law Firm...
-
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
DUBLIN--(BUSINESS WIRE)--Prothena partners presented clinical data updates for prasinezumab for Parkinson’s and BMS-986446 for Alzheimer’s disease at AD/PD™ 2026...
-
Rosen Law Firm Encourages Super Micro Computer, Inc. Investors to Inquire About Securities Class Action Investigation – SMCI
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Super Micro Computer, Inc. (NASDAQ: SMCI) resulting from allegations that Super Micro Computer, Inc. may have issued materially misleading business information to the investing public. So what: If you purchased Super Micro securities you may be entitled to compensation without payment of any out of pocket fees or costs through...
-
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Lufax Holding Ltd Investors – LU
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Lufax Holding Ltd (NYSE: LU) between April 7, 2023 and January 26, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Lufax investors under the federal securities laws. To join the Lufax class action, go to https://rosenlegal.com/submit-form/?case_id=53703 or call Phillip Kim, Esq. toll-fre...
-
Law Offices of Frank R. Cruz Encourages Hercules Capital, Inc. (HTGC) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Hercules Capital, Inc. (HTGC) Shareholders To Inquire About Securities Fraud Class Action...
-
Telekom Srbija eröffnet 9. Shop in Deutschland und erreicht Meilenstein beim Ausbau
BELGRAD, Serbien--(BUSINESS WIRE)--Die Telekom Srbija Group eröffnet am 26. März in Offenbach ihren 9. Shop in Deutschland und setzt damit einen Meilenstein beim Ausbau ihrer Präsenz in einem der größten Telekommunikationsmärkte Europas. Für das Unternehmen ist Deutschland zugleich ein zentraler internationaler Wachstumsmarkt. Der neue Shop in Offenbach ist ein weiterer Schritt in Telekom Srbijas Plan, in Deutschland ein bundesweites Shop- und Vertriebsnetz aufzubauen. Das Unternehmen baut sein...
-
SunnyFit Celebrates 4-Year Anniversary with “Year 4 Everyone” Challenge and Community Giveaway Event
INDUSTRY, Calif.--(BUSINESS WIRE)--SunnyFit, the free fitness app developed by Sunny Health & Fitness, is celebrating its fourth anniversary with the Year 4 Everyone Challenge & Giveaways Event, running from March 6 through March 26, 2026. The celebration highlights the platform’s growing global community of nearly half a million users and introduces a series of challenges, rewards, and prize giveaways. The anniversary celebration will conclude with the Year 4 Everyone Livestream &...
-
Aelis Farma annonce le démarrage réussi du recrutement de l’étude clinique de Phase 2B avec AEF0217 pour le traitement des troubles comportementaux et cognitifs chez les personnes avec un syndrome de Down (trisomie 21)
BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les maladies cérébrales et périphériques impliquant le récepteur CB1, annonce aujourd’hui, à l’occasion de la Journée mondiale de la trisomie 21, le lancement réussi de son étude clinique de Phase 2B avec AEF0217 pour le traitement des troubles comportementaux et cognitifs a...
-
Aelis Farma announces the successful start of the recruitment of the Phase 2B clinical trial with AEF0217 for the treatment of behavioral and cognitive impairments of people with Down syndrome (Trisomy 21)
BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain and peripheral diseases involving the CB1 receptor, announces today, on World Down Syndrome Day, the successful launch of its Phase 2B clinical trial with AEF0217 for the treatment of the behavioral and cognitive impairments associated with Down syndrome (Trisomy 21), with recruitment now underway...
-
「YOUR ONE AND ONLY. Biore全球品牌活動」於韓國聖水洞舉行
東京--(BUSINESS WIRE)--(美國商業資訊)-- Kao Corporation旗下防曬品牌Bioré UV於近日舉辦了「YOUR ONE AND ONLY. Biore全球品牌活動」,以慶祝其全球宣傳活動「SUNLIGHT IS YOUR SPOTLIGHT.」的啟動。該活動特邀世界知名男團Stray Kids出席典禮。活動中,全體八位成員登台亮相,首次公開了與Bioré UV合作的音樂作品——歌曲《Endless Sun》的主題影片,並參與了座談會,分享了創作過程中的獨家故事。 專題網站:https://www.kao.co.jp/bioreuv/sunlightisyourspotlight/en/ 全球擴張與韓國市場策略 在活動開場時,Kao公布了旗下產品目前已行銷66個國家與地區的Bioré UV的全球戰略,以及全面進軍韓國市場的計畫。Kao護膚事業部(Bioré)副總裁Emi Kobayashi在演講中闡述了公司的宏偉願景:「韓國是Bioré全球策略中最重要的樞紐之一。我們相信,進軍護膚理念高度成熟的韓國市場,是Bioré持續進化為真正全球化品牌的重要一步。」...